Local production of inflammatory mediators during childhood parainfluenza virus infection

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages

  El Feghaly, Rana E ^a   McGann, Lindsay ^a   Bonville, Cynthia A ^a   Branigan, Patrick J ^b   Suryadevera, Manika ^a   Rosenberg, Helene F ^c   Domachowske, Joseph B ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b CENTOCOR INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Innate immunity; Parainfluenza virus; Respiratory viral infection

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; INFLAMMATION; LARYNGOTRACHEOBRONCHITIS; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; PARAMYXOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEOMICS; SCHOOL CHILD; T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION;

EID: 77950238237     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d5da2a     Document Type: Article

References (40)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917-1928.
2. Griffin MR, Walker FJ, Iwane MK, et al; New Vaccine Surveillance Network Study Group. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J. 2004;23(suppl 11):S188-S192.
3. Reed G, Jewett PH, Thompson J, et al. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old., J Infect Dis., 1997, 175, 807-813.
4. Glezen WP, Loda FA, Clyde WA Jr, et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971;78:397-406.
5. Henrickson KJ, Hoover S, Kehl KS, et al. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004;23(suppl 1):S11-S18.
6. Counihan ME, Shay DK, Holman RC, et al. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J. 2001;20:646-653.
7. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004; 113:1758-1764.
8. Weinberg GA, Hall CB, Iwane MK, et al; New Vaccine Surveillance Network. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalizations. J Pediatr. 2009;154:694-699.
9. Henrickson K, Ray R, Belshe R. Parainfluenza viruses. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995:1489
10. Laurichesse H, Dedman D, Watson JM, et al. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol. 1999;15:475-484.
11. Walker TA, Khurana S, Tilden SJ. Viral respiratory infections. Pediatr Clin North Am. 1994;41:1365-1381.
12. Lau SK, To WK, Tse PW, et al. Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol. 2005;43:4515-4521.
13. Marx A, Torok TJ, Holman RC, et al. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human para-influenza virus 1 epidemics. J Infect Dis. 1997;176:1423-1427.
14. Glezen WP, Frank AL, Taber LH, et al. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis. 1984;150:851-857.
15. Denny FW, Murphy TF, Clyde WA Jr, et al. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71:871-876.
16. Bonville CA, Mehta PA, Krilov LR, et al. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell Immunol. 2001;213:134-140.
17. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J. 1999;18:115-122.
18. Noah TL, Ivins SS, Murphy P, et al. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin Immunol. 2002;104:86-95.
19. Hornsleth A, Loland L, Larsen LB. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol. 2001;21:163-170.
20. Abu-Harb M, Bell F, Finn A, et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J. 1999;14: 139-143.
21. Joshi P, Kakakios A, Jayasekera J, et al. A comparison of IL-2 levels in nasopharyngeal and endotracheal aspirates of babies with respiratory syncytial viral bronchiolitis. J Allergy Clin Immunol. 1998;102(4 pt 1):618-620.
22. Matsuda K, Tsutsumi H, Okamoto Y, et al. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diag Lab Immunol. 1995;2:322-324.
23. Smyth RL, Mobbs KJ, O'Hea U, et al. Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol. 2002; 33:339-346.
24. Harrison AM, Bonville CA, Rosenberg HF, et al. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999;159:1918-1924.
25. Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J. 2002;21:457-461.
26. Garofalo RP, Patti J, Hintz KA, et al. Macrophage inflammatory protein-1 alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis. 2001;184:393-399.
27. Miller AL, Bowlin TL, Lukacs NW. Respiratory syncytial virus induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis. 2004;189:1419-1430.
28. Moro MR, Bonville CA, Suryadevara M, et al. Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr Infect Dis J. 2009;28:376-380.
29. Madden JF, Burchette JL Jr, Hale LP. Pathology of parainfluenza virus infection in patients with congenital immunodeficiency syndromes. Hum Pathol. 2004;35:594-603.
30. Gern JE, Martin MS, Anklam KA, et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol. 2002;13:386-393.
31. Haeberle HA, Kuziel WA, Dieterich HJ, et al. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1a in lung pathology. J Virol. 2001;75:878-890.
32. Jafri HS, Chavez-Bueno S, Mejias A, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsive-ness in mice. J Infect Dis. 2004;189:1856-1865.
33. Blanco JC, Richardson JY, Darnell ME, et al. Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats. J Infect Dis. 2002;185:1780-1785.
34. Bonville CA, Bennett NJ, Koehnlein M, et al. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology. 2006;69:53-59.
35. Roger T, Bresser P, Snoek M, et al. Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus 4-infected NCI-H292 cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L1048-L1055.
36. Geelhoed GC, Turner J, MacDonald WB. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ. 1996;313:140-142.
37. Kairys SW, Olmstead EM, O'Connor GT. Steroid treatment of laryngotra-cheitis: A meta-analysis of the evidence from randomized trials. Pediatrics. 1989;83:683-693.
38. Johnson DW, Jacobson S, Edney PC. A comparison of nebulized budes-onide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998;339:498-503.
39. Klassen TP, Craig WR, Moher D. Nebulized budesonide and oral dexa-methasone for treatment of croup. JAMA. 1998;279:1629-1632.
40. Fry AM, Curns AT, Harbour K, et al. Seasonal trends of human parainfluenza virus infections: United States, 1990-2004. Clin Infect Dis. 2006;43: 1016-1022.